UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 348

Sortiert nach

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Clinical infectious diseases, 2023-07

2023

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

Clinical infectious diseases, 2006-09, Vol.43 (Supplement-2), p.S49-S56

2006

Link zum Volltext

Verfügbarkeit prüfen

Can We Really Use ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ß-Lactamase-Producing Bacteria?

Clinical infectious diseases, 2012-01, Vol.54 (2), p.175-177

2012

Link zum Volltext

Verfügbarkeit prüfen

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

Clinical infectious diseases, 2016-07, Vol.63 (2), p.234-241

2016

Link zum Volltext

Verfügbarkeit prüfen

Infectious Diseases Physicians: Leading the Way in Antimicrobial Stewardship

Clinical infectious diseases, 2018-03, Vol.66 (7), p.995-1003

2018

Link zum Volltext

Verfügbarkeit prüfen

Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection

The Journal of infectious diseases, 2021-12, Vol.224 (12), p.2133-2147

2021

Link zum Volltext

Verfügbarkeit prüfen

An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the “Perfect Storm”

The Journal of infectious diseases, 2018-01, Vol.217 (1), p.82-92

2018

Link zum Volltext

Verfügbarkeit prüfen

Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens

Clinical infectious diseases, 2019-11, Vol.69 (Supplement_7), p.S519-S520

Bonomo, Robert A

2019

Link zum Volltext

Verfügbarkeit prüfen

A 17-Year Nationwide Study of Burkholderia cepacia Complex Bloodstream Infections Among Patients in the United States Veterans Health Administration

Clinical infectious diseases, 2017-10, Vol.65 (8), p.1327-1334

2017

Link zum Volltext

Verfügbarkeit prüfen

International Epidemiology of Carbapenemase-Producing Escherichia coli

Clinical infectious diseases, 2023-08, Vol.77 (4), p.499-509

2023

Link zum Volltext

Verfügbarkeit prüfen

The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world

Journal of travel medicine, 2017-04, Vol.24 (suppl_1), p.S44-S51

2017

Link zum Volltext

Verfügbarkeit prüfen

Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children

The Pediatric infectious disease journal, 2019-06, Vol.38 (6), p.595

2019

Link zum Volltext

Verfügbarkeit prüfen

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2021-04, Vol.72 (7), p.1109-1116

2021

Link zum Volltext

Verfügbarkeit prüfen

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Clinical infectious diseases, 2022-07, Vol.74 (12), p.2089-2114

2022

Link zum Volltext

Verfügbarkeit prüfen

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2021-04, Vol.72 (7), p.e169-e183

2021

Link zum Volltext

Verfügbarkeit prüfen

Cefepime: a reappraisal in an era of increasing antimicrobial resistance

Expert review of anti-infective therapy, 2008-12, Vol.6 (6), p.805-824

2008

Link zum Volltext

Verfügbarkeit prüfen

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Clinical infectious diseases, 2022-08, Vol.75 (2), p.187-212

2022

Link zum Volltext

Verfügbarkeit prüfen

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

Clinical infectious diseases, 2019-01, Vol.68 (3), p.519-524

2019

Link zum Volltext

Verfügbarkeit prüfen

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)

Clinical infectious diseases, 2019-05, Vol.68 (11), p.1961-1967

2019

Link zum Volltext

Verfügbarkeit prüfen

A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World

Clinical infectious diseases, 2019-09, Vol.69 (8), p.1446-1455

2019

Link zum Volltext

Verfügbarkeit prüfen

Carbapenemase-Producing Organisms: A Global Scourge

Clinical infectious diseases, 2018-04, Vol.66 (8), p.1290-1297

2018

Link zum Volltext

Verfügbarkeit prüfen

New Delhi Metallo-β-Lactamase and Multidrug Resistance: A Global SOS?

Clinical infectious diseases, 2011-02, Vol.52 (4), p.485-487

Bonomo, Robert A.

2011

Link zum Volltext

Verfügbarkeit prüfen

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Children: Old Foe, Emerging Threat

Clinical infectious diseases, 2015-05, Vol.60 (9), p.1389-1397

2015

Link zum Volltext

Verfügbarkeit prüfen

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

Clinical infectious diseases, 2018-01, Vol.66 (2), p.163-171

2018

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 348

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Microbiology

ThemaBiological And Medical Sciences

KollektionJournals@Ovid

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(333)
Mit Volltextzugriff
(334)

Publikationsform

Artikel
(346)
Berichte
(2)

Sprache

Englisch
(348)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(152)
Science & Technology
(152)
Infectious Diseases
(128)
Humans
(109)
Microbiology
(107)
Immunology
(78)
Anti-Bacterial Agents - Therapeutic Use
(58)
Anti-Bacterial Agents - Pharmacology
(52)
Abstracts
(44)
Microbial Sensitivity Tests
(34)
Male
(33)
Female
(32)
Antibiotics
(30)
Drug Resistance
(30)
Pharmacology & Pharmacy
(29)
Beta-Lactamases - Genetics
(25)
Drug Resistance, Bacterial
(24)
Aged
(22)
Infections
(21)
Carbapenems - Pharmacology
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections

Mechanisms of Multidrug Resistance in Acinetobacter Species and Pseudomonas aeruginosa

Can We Really Use ß-Lactam/ß-Lactam Inhibitor Combinations for the Treatment of Infections Caused by Extended-Spectrum ß-Lactamase-Producing Bacteria?

Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor Combinations

Infectious Diseases Physicians: Leading the Way in Antimicrobial Stewardship

Monoclonal Antibody Requires Immunomodulation for Efficacy Against Acinetobacter baumannii Infection

An Analysis of the Epidemic of Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Convergence of Two Evolutionary Mechanisms Creates the “Perfect Storm”

Cefiderocol: A Novel Siderophore Cephalosporin Defeating Carbapenem-resistant Pathogens

A 17-Year Nationwide Study of Burkholderia cepacia Complex Bloodstream Infections Among Patients in the United States Veterans Health Administration

International Epidemiology of Carbapenemase-Producing Escherichia coli

The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world

Community Origins and Regional Differences Highlight Risk of Plasmid-mediated Fluoroquinolone Resistant Enterobacteriaceae Infections in Children

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Infectious Diseases Society of America Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant Acinetobacter baumannii, and Stenotrophomonas maltophilia Infections

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Cefepime: a reappraisal in an era of increasing antimicrobial resistance

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Ceftazidime/Avibactam, Meropenem/Vaborbactam, or Both? Clinical and Formulary Considerations

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

Sequential, Multiple-Assignment, Randomized Trials for COMparing Personalized Antibiotic StrategieS (SMART-COMPASS)

A Primer on AmpC β-Lactamases: Necessary Knowledge for an Increasingly Multidrug-resistant World

Carbapenemase-Producing Organisms: A Global Scourge

New Delhi Metallo-β-Lactamase and Multidrug Resistance: A Global SOS?

Extended-Spectrum β-Lactamase–Producing Enterobacteriaceae in Children: Old Foe, Emerging Threat

Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

Aktive Filter

Suchergebnisse filtern